Pharsight Announces Fiscal Third Quarter 2008 Earnings Release Date and Conference Call

Friday, January 11, 2008 General News J E 4
MOUNTAIN VIEW, Calif., Jan. 10 PharsightCorporation (Nasdaq: PHST), a leading provider of software and strategicservices for optimizing clinical drug development, announced today that itwill release financial results for the fiscal third quarter 2008, which endedDecember 31, 2007, after the market closes on Thursday, January 24, 2008. TheCompany will host a conference call and webcast on Friday, January 25, 2008 at10:00 a.m. Pacific Time to discuss the Company's fiscal third quarter results,and current corporate developments. The dial-in number for the conferencecall is 800-240-2134 for domestic participants and 303-262-2130 forinternational participants.

A taped replay of the conference call will also be available beginningapproximately one hour after the call's conclusion and will remain availablefor seven days. This replay can be accessed by dialing 800-405-2236 fordomestic callers, using passcode 11106750# and 303-590-3000 for internationalcallers, using passcode 11106750#. To access the live webcast of the call, goto Pharsight's website at An archived webcast willalso be available at

About Pharsight Corporation

Pharsight Corporation develops and markets integrated products andservices that enable pharmaceutical and biotechnology companies to achievesignificant and enduring improvements in the development and use oftherapeutic products. The company's goal is to help customers reduce the time,cost and risk of drug development, as well as optimize the post-approvalmarketing and use of pharmaceutical products.

Pharsight's approach enhances the fundamental element of drug developmentsuccess: strong decision-making. By adopting the Pharsight approach, customersacquire a new decision-making process with the potential to systematicallyimprove every level and phase of their business and scientific processes.Pharsight Corporation is headquartered in Mountain View, California.Information about Pharsight is available at

SOURCE Pharsight Corporation


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
FLOW(TM): Exercise Your Body and Mind While at Wor...
eyeonics' Fourth Quarter Sales Increase 144%